BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10943862)

  • 21. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S; Nara K; Rifkin DB
    J Cell Biol; 1993 Apr; 121(2):439-48. PubMed ID: 8096847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis.
    Salminen H; Vuorio E; Säämänen AM
    Arthritis Rheum; 2001 Apr; 44(4):947-55. PubMed ID: 11315934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes.
    Qi WN; Scully SP
    J Orthop Res; 2003 Mar; 21(2):282-9. PubMed ID: 12568960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa.
    Johnson K; Hashimoto S; Lotz M; Pritzker K; Terkeltaub R
    Am J Pathol; 2001 Jul; 159(1):149-63. PubMed ID: 11438463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of intracellular reactive oxygen species level in chondrocytes by IGF-1, FGF, and TGF-beta1.
    Jallali N; Ridha H; Thrasivoulou C; Butler P; Cowen T
    Connect Tissue Res; 2007; 48(3):149-58. PubMed ID: 17522998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes.
    Shuler FD; Georgescu HI; Niyibizi C; Studer RK; Mi Z; Johnstone B; Robbins RD; Evans CH
    J Orthop Res; 2000 Jul; 18(4):585-92. PubMed ID: 11052495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of insulin-like growth factor binding protein-2 in chondrocytes of bovine articular cartilage.
    Morales TI; Hunziker EB
    J Orthop Res; 2003 Mar; 21(2):290-5. PubMed ID: 12568961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes.
    Loeser RF; Pacione CA; Chubinskaya S
    Arthritis Rheum; 2003 Aug; 48(8):2188-96. PubMed ID: 12905472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chondrocytes isolated from tibial dyschondroplasia lesions and articular cartilage revert to a growth plate-like phenotype when cultured in vitro.
    Wu LN; Ishikawa Y; Genge BR; Wuthier RE
    J Cell Physiol; 2005 Jan; 202(1):167-77. PubMed ID: 15389532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglutaminase contributes to CPPD crystal formation in osteoarthritis.
    Heinkel D; Gohr CM; Uzuki M; Rosenthal AK
    Front Biosci; 2004 Sep; 9():3257-61. PubMed ID: 15353354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of nitrotyrosine in aging and osteoarthritic cartilage: Correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1.
    Loeser RF; Carlson CS; Del Carlo M; Cole A
    Arthritis Rheum; 2002 Sep; 46(9):2349-57. PubMed ID: 12355482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential upregulation of the three transforming growth factor beta isoforms in human osteoarthritic cartilage.
    Pombo-Suarez M; Castaño-Oreja MT; Calaza M; Gomez-Reino J; Gonzalez A
    Ann Rheum Dis; 2009 Apr; 68(4):568-71. PubMed ID: 18467513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes.
    Baugé C; Attia J; Leclercq S; Pujol JP; Galéra P; Boumédiene K
    Arthritis Rheum; 2008 Jan; 58(1):221-6. PubMed ID: 18163503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
    Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
    Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation.
    Alvarez J; Horton J; Sohn P; Serra R
    Dev Dyn; 2001 Jul; 221(3):311-21. PubMed ID: 11458391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of articular cartilage frictional properties by transforming growth factor beta, interleukin-1beta, and oncostatin M.
    Gleghorn JP; Jones AR; Flannery CR; Bonassar LJ
    Arthritis Rheum; 2009 Feb; 60(2):440-9. PubMed ID: 19180510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophy.
    Bobacz K; Sunk IG; Hayer S; Amoyo L; Tohidast-Akrad M; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2008 Jan; 58(1):109-18. PubMed ID: 18163510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.
    Scharstuhl A; Vitters EL; van der Kraan PM; van den Berg WB
    Arthritis Rheum; 2003 Dec; 48(12):3442-51. PubMed ID: 14673995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.